Home
AMAG Pharmaceuticals

AMAG Pharmaceuticals Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainamagpharma.com

Year Founded1981

Employees201 - 500

Annual Revenue$200M - $500M

AMAG Pharmaceuticals

AMAG Pharmaceuticals (including company regionals)

amagpharma.com

See more website traffic and engagement information

AMAG Pharmaceuticals Revenue up to May 2026 is 200M - 500M

revenue generated by AMAG Pharmaceuticals top domains

AMAG Pharmaceuticals top domains revenue over 3 years

Revenue for AMAG Pharmaceuticals top domains

amagpharma.com200M - 500M

See more with Sales Intelligence

Total visits to AMAG Pharmaceuticals's top domains

Understand AMAG Pharmaceuticals market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in AMAG Pharmaceuticals's top domains

Analyze AMAG Pharmaceuticals engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on AMAG Pharmaceuticals's top domains

See how AMAG Pharmaceuticals keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

AMAG Pharmaceuticals top competitors by domain

Top similar sites in May 2026, ranked by their affinity

amylin.comCompany NameAmylin Pharmaceuticals, Inc.Employees1001 - 5000HQUnited States, California, San DiegoAnnual revenue$200M - $500MTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by AMAG Pharmaceuticals

These are the website technologies, by industry, used by AMAG Pharmaceuticals top domains

Email Services (4)

G Suite

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Content Management System (2)

WordPress

More Technologies

5

See all

News & Signals from AMAG Pharmaceuticals

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAmagpharma launched Intrarosa on Jul 1st '17.For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause.

NewsPiekos left Amagpharma as Executive Vice President, Chief Financial Officer and Treasurer on Feb 28th '21.Mr. Piekos joins Gemini from AMAG Pharmaceuticals, where he was most recently Executive Vice President, Chief Financial Officer and Treasurer.